Results 231 to 240 of about 328,577 (288)
Baseline characteristics for the vericiguat global study in participants with chronic heart failure (VICTOR) trial. ARNI, angiotensin receptor/neprilysin inhibitor; CRT, cardiac resynchronization therapy; eGFR, estimated glomerular filtration rate; GDMT, guideline‐directed medical therapy; HF, heart failure; HFrEF, heart failure with reduced ejection ...
Clara I. Saldarriaga+21 more
wiley +1 more source
Prescriptions for Excellence in Health Care Spring 2011 Download PDF [PDF]
core +1 more source
Patient satisfaction with ambulatory care services delivery and respect for patient rights: findings from 2022 national survey in Rwanda. [PDF]
Ntihabose CK+6 more
europepmc +1 more source
Clinical applications of urinary sodium in heart failure from prognostic marker to clinical tool
ESC Heart Failure, EarlyView.
Dauw Jeroen
wiley +1 more source
Differences in baseline characteristics between major trials of intravenous (IV) iron therapy in heart failure. LVEF, left ventricular ejection fraction; SGLT2, sodium–glucose cotransporter 2. Aims Prior randomized trials have reported conflicting evidence regarding the efficacy of intravenous (IV) iron in patients with heart failure with reduced ...
Stefan D. Anker+44 more
wiley +1 more source
Integrating Ambulatory Care Pharmacists Into Value-Based Primary Care: A Scalable Solution to Chronic Disease. [PDF]
Blood AJ+10 more
europepmc +1 more source
The beneficial effects of finerenone in patients with heart failure (HF) and mildly reduced or preserved ejection fraction were consistent, regardless of a history of chronic obstructive pulmonary disease (COPD) status. BMI, body mass index; LVEF, left ventricular ejection fraction; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide.
Jawad H. Butt+16 more
wiley +1 more source